FAM120A acts as a new effector in progranulin/EphA2-driven bladder cancer
Bladder cancer remains one of the most lethal malignancies in the United States, with an estimated 84,530 new cases and ...
Tag: molecular targets for bladder cancer treatment
Blocking TGM2 Boosts Cisplatin Response in MSH2-Deficient Bladder Cancer
A groundbreaking study has emerged from the intersection of molecular biology and oncology, revealing an innovative approach to overcoming chemotherapy ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!